Doença de Pott após tratamento intravesical com Mycobacterium bovis BCG

Doença de Pott após tratamento intravesical com Mycobacterium bovis BCG

Resumo: Os autores descrevem um caso de osteomielite da coluna vertebral a M. Bovis BCG num doente de 83 anos, com história prévia de carcinoma urotelial da bexiga, submetido a ressecção trans-uretral e imunoterapia com BCG intravesical durante 3 anos. Cinco anos após realização desta terapêutica, o...

Full description

Bibliographic Details
Main Authors:	Samaher Tannira, Pedro Figueiredo, Catarina Zilhão, Francisco Silva, Alberto Mello e Silva
Format:	Article
Language:	English
Published:	Sociedade Galega de Medicina Interna 2016-03-01
Series:	Galicia Clínica
Subjects:	Doença de Pott M. bovis BCG intravesical Carcinoma de bexiga
Online Access:	http://www.galiciaclinica.info/publicacion.asp?f=837

Similar Items

Pott's disease post intravesical BCG
by: Anika Jain
Published: (2023-01-01)

Sporotrichoid distributed tuberculous panniculitis as a late complication of intravesical bacillus Calmette–Guérin (BCG) immunotherapy
by: Nina Nielens, et al.
Published: (2022-04-01)

Cistectomia com reconstrução de neobexiga ortotópica ileal para tratamento de bexiga contraída após aplicação de bacilo de Calmette-Guérin intravesical
by: José Eduardo Vetorazzo Filho, et al.

A case of disseminated M. bovis bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017–2022
by: Masashi Nishimura, et al.
Published: (2023-01-01)

An Investigation into Improvement of Stability and Efficacy of Intravesical BCG Formulations Using Freeze-Drying Technique
by: Hamidreza Hozouri, et al.
Published: (2021-01-01)

Mycobacterium Bovis Spondylodiscitis: A Rare Complication of Intravesical Bacillus Calmette-Guérin Therapy
by: Frédéric Quatannens, et al.
Published: (2022-07-01)

Culture-proven disseminated Mycobacterium Bovis infection (BCG-Osis) following intravesical BCG immunotherapy in a patient with bladder carcinoma-in-situ: ‘Case report’
by: Ahmed Ghonaimy, et al.
Published: (2022-02-01)

Vaccination-related Mycobacterium bovis BCG Infection
by: Anna Liberek, et al.
Published: (2006-05-01)

Protective role of intravesical BCG in COVID-19 severity
by: Héctor Gallegos, et al.
Published: (2021-03-01)

Complications of intravesical BCG therapy in non-muscle invasive bladder cancer: our tertiary care centre experience
by: Vivek Sharma, et al.
Published: (2020-12-01)

Incidental discovery of a case of renal tuberculoma after intravesical BCG treatment
by: Komi Hola Sikpa, et al.
Published: (2022-11-01)

Phosphate starvation enhances phagocytosis of Mycobacterium bovis/BCG by macrophages
by: Patricia Espinosa-Cueto, et al.
Published: (2020-06-01)

Secondary Haemophagocytic Lymphohistiocytosis Syndrome (HLH) After Intravesical Instillation of Bacillus Calmette-Guérin (BCG): A Case Report and Review of the Literature
by: Konstantinos Manganas, et al.
Published: (2022-10-01)

BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
by: Sarah Lidagoster, et al.
Published: (2024-02-01)

Vascular graft infections caused by Mycobacterium bovis BCG after BCG immunotherapy for non-muscle-invasive bladder cancer: Case report and review of literature
by: Stefania Arsuffi, et al.
Published: (2023-05-01)

Mycobacterium bovis BCG: the importance of an accurate identification in the diagnostic routine
by: Antonella Grottola, et al.
Published: (2010-09-01)

Granulomas do pênis: uma complicação rara da terapia intravesical com Bacilo Calmette-Guérin Granulomas of the penis: a rare complication of intravesical therapy with Bacillus Calmette-Guerin
by: Sara Isabel Alcântara Lestre, et al.
Published: (2011-08-01)

Asymptomatic renal BCG granulomatosis: An unusual complication of intravesical BCG therapy for carcinoma urinary bladder
by: Suresh Bhat, et al.
Published: (2015-01-01)

Extracellular forms of Mycobacterium bovis BCG in the mucosal lymphatic tissues following oral vaccination
by: Wenzel Czepluch, et al.
Published: (2013-01-01)

Advances in the characterization of a proteol iposome derived from Mycobacterium bovis BCG as vaccine candidate against tuberculosis
by: Nadine Alvarez-Cabrera, et al.
Published: (2014-12-01)

Mechanisms of cell accumulation induced by Mycobacterium bovis BCG
by: Octávio Menezes-de-Lima-Júnior, et al.
Published: (1997-12-01)

Multisystemic BCGitis: A rare complication of intravesical BCG immunotherapy for bladder cancer
by: Ana T. Vilares, MD, et al.
Published: (2022-07-01)

DosR’s multifaceted role on Mycobacterium bovis BCG revealed through multi-omics
by: Yingying Cui, et al.
Published: (2023-11-01)

Late-onset granulomatous prostatitis following intravesical bacille Calmette-Guerin therapy: case report
by: Octavio Castillo Cádiz, et al.
Published: (2016-06-01)

Two-stage posterior decompression and fusion for tuberculous spondylitis after intravesical bacillus Calmette-Guerin instillation
by: Hiroki Ohata, et al.
Published: (2021-01-01)

Interstitial pneumonitis secondary to intravesical bacillus calmette-guerin for carcinoma in-situ of the bladder
by: Eric K. Diner, et al.
Published: (2004-10-01)

Empleo de una PCR-multiplex para diferenciar caprinos vacunados con M. bovis BCG de infectados con M. bovis de campo
by: Isaura Carolina Ramírez Casillas, et al.
Published: (2012-01-01)

Complete response to intravesical gemcitabine in non‐muscle invasive bladder cancer patient after BCG failure: A case report and literature review
by: Fouad Nahhat, et al.
Published: (2022-09-01)

A case of infectious endocarditis due to BCG
by: Alice Fournier, et al.
Published: (2015-06-01)

Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis
by: C. Kanipe, et al.
Published: (2022-11-01)

M. BOVIS BCG-1 (RUSSIA) SUB-STRAIN GENOME STABILITY INVESTIGATION WITHIN THE ENTIRE PRODUCTION PROCESS
by: E. V. Otrashevskaya, et al.
Published: (2018-04-01)

Enhanced immunogenicity of Mycobacterium bovis BCG through CRISPRi mediated depletion of AftC
by: Bala T.S.A. Madduri, et al.
Published: (2022-12-01)

A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice
by: V.L. Petricevich, et al.
Published: (2001-01-01)

Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route
by: Zhengzhong Xu, et al.
Published: (2023-11-01)

Human Properdin Modulates Macrophage: Mycobacterium bovis BCG Interaction via Thrombospondin Repeats 4 and 5
by: Maha Ahmed Al-Mozaini, et al.
Published: (2018-05-01)

Mycobacterium bovis BCG–Associated Osteomyelitis/Osteitis, Taiwan
by: Nan-Chang Chiu, et al.
Published: (2015-03-01)

Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
by: Christopher James, et al.
Published: (2023-04-01)

Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer
by: Azharuddin Mohammed, et al.
Published: (2017-12-01)

Intravesical bacillus Calmette–Guérin-induced myopathy presenting as rhabdomyolysis: a case report
by: Chae Hun Lee, et al.
Published: (2023-10-01)

Protective Effect of Oral BCG and Inactivated Mycobacterium bovis Vaccines in European Badgers (Meles meles) Experimentally Infected With M. bovis
by: Ana Balseiro, et al.
Published: (2020-02-01)